Kane Biotech (KNE.V) on Tuesday said it closed an over-subscribed private placement of share units that raised $1.16 million.
The company placed 23.2-million units priced at at $0.05 apiece and made up of a share and an 18-month warrant to buy a share for $0.06.
Proceeds of the offering will be used for working capital and general corporate needs.
Shares of the company were last seen down $0.005 to $0.03 on the TSX Venture Exchange.
Price: $0.03, Change: $-0.01, Percent Change: -14.29%